Dealing with multiple myeloma (MM) with myxoma virus (MYXV) removed a majority of malignant cells in preclinical studies, report researchers. Furthermore, introduction of MYXV had no impact on the particular bone marrow compartment and elicited a strong immune reaction that eradicated disease in some animals.